Trial Profile
Avastin-Injections in Age Related Macular Degeneration: Prospective Study for Optimal Frequency and Follow-up Determination
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Age-related macular degeneration; Wet age-related macular degeneration
- Focus Therapeutic Use
- 16 Sep 2014 New trial record
- 01 Mar 2011 Recruitment completed according to results published in the Acta Ophthalmologica.